67221 Ocular photodynamic therapy
Also known as: photodynamic therapy, PDT, Visudyne, verteporfin therapy
Ocular photodynamic therapy involving intravenous injection of photosensitive dye followed by low-power laser activation to treat choroidal neovascular lesions without thermal damage.
Clinical Context
Used for pathologic myopia, polypoidal choroidal vasculopathy, and some choroidal neovascular lesions; requires strict light precautions post-treatment.
RVU Breakdown
| Work RVU | 3.36 |
| Practice Expense RVU | 4.89 |
| Malpractice RVU | 0.26 |
| Total RVU | 8.51 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.